Lymphoma Working Party (LWP)
Study type:
Study number:
2025-R-09
Type of treatment:
Allogeneic
Diseases:
Non-Hodgkin’s Lymphoma (NHL)
Short title:
CPI after allo-HCT in r/r cHL
Primary objective:
To assess the efficacy and safety profile of CPI after allo-HCT in r/r cHL patients
Key inclusion criteria:
• age -18 years
• diagnosis of classic Hodgkin lymphoma
• relapsed and refractory course of the disease (all who received alloHSCT are considered r/r)
• patients with relapse or progression after allo-HCT and before post-CPI therapy
• CPI-containing therapy after allo-HCT between 2016 and 2022
Baseline information, transplantation characteristics of eligible patients as well as outcome data will be downloaded from the EBMT registry (MED A data) in the time period 2016-2022
• diagnosis of classic Hodgkin lymphoma
• relapsed and refractory course of the disease (all who received alloHSCT are considered r/r)
• patients with relapse or progression after allo-HCT and before post-CPI therapy
• CPI-containing therapy after allo-HCT between 2016 and 2022
Baseline information, transplantation characteristics of eligible patients as well as outcome data will be downloaded from the EBMT registry (MED A data) in the time period 2016-2022
Country:
All EBMT member countries
Principal investigator:
Dr. Liudmila Fedorova
EBMT Study coordinator:
Diane Marie Bacabac
Study coordinator email:
diane.bacabac@ebmt.org
EBMT Study Unit:
Paris Study Unit
Reason for processing personal data:
Patients’ data is needed to be able to identify the patient and calculate age at any time (impact on SAEs and response to clinical medications). Health care personal data is part of the CV collected for evidence of proper qualification for running the trial.
Categories of personal data collected:
DOB/YOB, gender
Medical data already reported to the EBMT Registry
Study Specific Questionnaire (MED-C)
Recipients who may access the data:
Paris Study Unit
Statistical Unit
3rd-party processors of Personal Data on behalf of EBMT/Service provider:
No
Privacy notices
Article 6 lawful basis for processing personal data:
Article 6.1 (a) - Consent (Collection)
Article 9 basis for processing special category data:
Article 9(2) (a) - Consent (Collection)
Data Protection Impact Assessments
Rights available to individuals:
Access
Data portability
Rectification
Objection
Deletion
Is a Data Protection Impact Assessment required?:
DPIA performed for EBMT Registry (WP & NIS Studies)
Retention Schedule (if possible):
at least 5 years after the final report or first publication of study results